AnitaH.ClaytonMD
Psychiatry • Charlottesville, VAProfessor, Psychiatric Medicine, University of Virginia School of Medicine
Dr. Clayton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2955 Ivy Rd
Charlottesville, VA 22903Phone+1 434-243-4646Fax+1 434-243-4743
Education & Training
University of Virginia Medical CenterResidency, Psychiatry, 1985 - 1988- University of Virginia Medical CenterInternship, Transitional Year, 1982 - 1983
University of Virginia School of MedicineClass of 1982
Certifications & Licensure
VA State Medical License 1985 - 2026
IL State Medical License 1983 - 1984- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
Clinical Trials
- Study of Supplementation of Antidepressants With Fish Oil to Improve Time to Clinical Response Start of enrollment: 2009 Sep 01
- Does Vilazodone Help With Antidepressant-associated Sexual Dysfunction? Start of enrollment: 2013 Jan 01
Publications & Presentations
PubMed
- 84 citationsSummit on Medical School Education in Sexual Health: Report of an Expert ConsultationEli Coleman, Joycelyn Elders, David Satcher, Alan W. Shindel, Sharon J. Parish
The Journal of Sexual Medicine. 2013-04-01 - 150 citationsThe blood brain barrier and the role of cytokines in neuropsychiatry.Atmaram Yarlagadda, Elizabeth D. Alfson, Anita H. Clayton
Psychiatry. 2009-11-01 - 60 citationsLack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder.Anita H. Clayton, John Zajecka, James M. Ferguson, Jacqueline K. Filipiak‐Reisner, Mark T. Brown
International Clinical Psychopharmacology. 2003-05-01
Press Mentions
Zuranolone Effective in Major DepressionMay 10th, 2023- Sage Therapeutics and Biogen Announce Consistent Clinically Meaningful Data for Zuranolone Across the LANDSCAPE and NEST Clinical Development Programs Presented at the European College of Neuropsychopharmacology (ECNP) CongressOctober 4th, 2021
- Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Launches the Desire Project to Promote MDMA-Assisted Psychotherapy Treatment for HSDDOctober 1st, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
